BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16815451)

  • 1. Differential gene expression in patients genetically predisposed to pancreatic cancer.
    Zervos EE; Tanner SM; Osborne DA; Bloomston M; Rosemurgy AS; Ellison EC; Melvin WS; de la Chapelle A
    J Surg Res; 2006 Oct; 135(2):317-22. PubMed ID: 16815451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
    Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
    Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.
    Logsdon CD; Simeone DM; Binkley C; Arumugam T; Greenson JK; Giordano TJ; Misek DE; Kuick R; Hanash S
    Cancer Res; 2003 May; 63(10):2649-57. PubMed ID: 12750293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
    Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK
    Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of the Tie-2 receptor and its ligands in human pancreatic tumors.
    Durkin AJ; Bloomston M; Yeatman TJ; Gilbert-Barness E; Cojita D; Rosemurgy AS; Zervos EE
    J Am Coll Surg; 2004 Nov; 199(5):724-31. PubMed ID: 15501112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma.
    Beger C; Ramadani M; Meyer S; Leder G; Krüger M; Welte K; Gansauge F; Beger HG
    Clin Cancer Res; 2004 Jun; 10(11):3780-7. PubMed ID: 15173085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent.
    Crnogorac-Jurcevic T; Missiaglia E; Blaveri E; Gangeswaran R; Jones M; Terris B; Costello E; Neoptolemos JP; Lemoine NR
    J Pathol; 2003 Sep; 201(1):63-74. PubMed ID: 12950018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma.
    Sato N; Maitra A; Fukushima N; van Heek NT; Matsubayashi H; Iacobuzio-Donahue CA; Rosty C; Goggins M
    Cancer Res; 2003 Jul; 63(14):4158-66. PubMed ID: 12874021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
    Jiang P; Watanabe H; Okada G; Ohtsubo K; Mouri H; Tsuchiyama T; Yao F; Sawabu N
    Cancer Sci; 2006 Nov; 97(11):1267-73. PubMed ID: 16965396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays.
    Stålberg P; Santesson M; Ekeblad S; Lejonklou MH; Skogseid B
    Surgery; 2006 Dec; 140(6):921-9; discussion 929-31. PubMed ID: 17188139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of molecular markers specific for pancreatic neuroendocrine tumors by genetic profiling of core biopsies.
    Bloomston M; Durkin A; Yang I; Rojiani M; Rosemurgy AS; Enkmann S; Yeatman TJ; Zervos EE
    Ann Surg Oncol; 2004 Apr; 11(4):413-9. PubMed ID: 15070602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of FAMPAC, a newly identified human pancreatic carcinoma cell line with a hereditary background.
    Eisold S; Ryschich E; Linnebacher M; Giese T; Nauheimer D; Wild A; Bartsch DK; Büchler MW; Schmidt J
    Cancer; 2004 May; 100(9):1978-86. PubMed ID: 15112280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer.
    Grubbs EG; Abdel-Wahab Z; Tyler DS; Pruitt SK
    Ann Surg Oncol; 2006 Dec; 13(12):1645-54. PubMed ID: 16957968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer.
    Zhang ML; Lu S; Zhou L; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):533-8. PubMed ID: 18842503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
    Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
    Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gamma-aminobutyric acid A receptor pi subunit is overexpressed in pancreatic adenocarcinomas.
    Johnson SK; Haun RS
    JOP; 2005 Mar; 6(2):136-42. PubMed ID: 15767729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic carcinoma cell lines with SMAD4 inactivation show distinct expression responses to TGFB1.
    Jonson T; Heidenblad M; Håkansson P; Gorunova L; Johansson B; Fioretos T; Höglund M
    Genes Chromosomes Cancer; 2003 Apr; 36(4):340-52. PubMed ID: 12619158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma.
    Crnogorac-Jurcevic T; Gangeswaran R; Bhakta V; Capurso G; Lattimore S; Akada M; Sunamura M; Prime W; Campbell F; Brentnall TA; Costello E; Neoptolemos J; Lemoine NR
    Gastroenterology; 2005 Nov; 129(5):1454-63. PubMed ID: 16285947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.